Patents by Inventor Richard Nause

Richard Nause has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Pharmaceutical compositions containing a DGAT1 inhibitor
    Patent number: 11304907
    Abstract: The present invention relates to a pharmaceutical composition comprising a) a therapeutically effective amount of a compound of formula (I), or a pharmaceutically acceptable salt thereof, b) one or more, e.g. 1, 2 or 3, surfactants with lubricant properties; c) one or more, e.g. 1, 2 or 3, dry binders with disintegrant properties; d) one or more, e.g. 1, 2 or 3, fillers, and e) one or more, e.g. 1, 2 or 3, disintegrants.
    Type: Grant
    Filed: March 31, 2020
    Date of Patent: April 19, 2022
    Assignee: Novartis AG
    Inventors: Hong Wen, Natrajan Kumaraperumal, Richard Nause
  • PHARMACEUTICAL COMPOSITIONS CONTAINING A DGAT1 INHIBITOR
    Publication number: 20200230062
    Abstract: The present invention relates to a pharmaceutical composition comprising a) a therapeutically effective amount of a compound of formula (I), or a pharmaceutically acceptable salt thereof, b) one or more, e.g. 1, 2 or 3, surfactants with lubricant properties; c) one or more, e.g. 1, 2 or 3, dry binders with disintegrant properties; d) one or more, e.g. 1, 2 or 3, fillers, and e) one or more, e.g. 1, 2 or 3, disintegrants.
    Type: Application
    Filed: March 31, 2020
    Publication date: July 23, 2020
    Inventors: Hong WEN, Natrajan KUMARAPERUMAL, Richard NAUSE
  • Pharmaceutical compositions containing a DGAT1 inhibitor
    Patent number: 10646446
    Abstract: The present invention relates to a pharmaceutical composition comprising a) a therapeutically effective amount of a compound of formula (I), or a pharmaceutically acceptable salt thereof, b) one or more, e.g. 1, 2 or 3, surfactants with lubricant properties; c) one or more, e.g. 1, 2 or 3, dry binders with disintegrant properties; d) one or more, e.g. 1, 2 or 3, fillers, and e) one or more, e.g. 1, 2 or 3, disintegrants.
    Type: Grant
    Filed: May 1, 2018
    Date of Patent: May 12, 2020
    Assignee: Novartis AG
    Inventors: Hong Wen, Natrajan Kumaraperumal, Richard Nause
  • PHARMACEUTICAL COMPOSITIONS CONTAINING A DGAT1 INHIBITOR
    Publication number: 20180243222
    Abstract: The present invention relates to a pharmaceutical composition comprising a) a therapeutically effective amount of a compound of formula (I), or a pharmaceutically acceptable salt thereof, b) one or more, e.g. 1, 2 or 3, surfactants with lubricant properties; c) one or more, e.g. 1, 2 or 3, dry binders with disintegrant properties; d) one or more, e.g. 1, 2 or 3, fillers, and e) one or more, e.g. 1, 2 or 3, disintegrants.
    Type: Application
    Filed: May 1, 2018
    Publication date: August 30, 2018
    Inventors: Hong WEN, Natrajan KUMARAPERUMAL, Richard NAUSE
  • PHARMACEUTICAL COMPOSITIONS CONTAINING A DGAT1 INHIBITOR
    Publication number: 20160374947
    Abstract: The present invention relates to a pharmaceutical composition comprising a) a therapeutically effective amount of a compound of formula (I), or a pharmaceutically acceptable salt thereof, b) one or more, e.g. 1, 2 or 3, surfactants with lubricant properties; c) one or more, e.g. 1, 2 or 3, dry binders with disintegrant properties; d) one or more, e.g. 1, 2 or 3, fillers, and e) one or more, e.g. 1, 2 or 3, disintegrants.
    Type: Application
    Filed: September 12, 2016
    Publication date: December 29, 2016
    Applicant: NOVARTIS AG
    Inventors: Hong Wen, Natrajan Kumaraperumal, Richard Nause
  • PHARMACEUTICAL COMPOSITIONS CONTAINING A DGAT1 INHIBITOR
    Publication number: 20150320687
    Abstract: The present invention relates to a pharmaceutical composition comprising a) a therapeutically effective amount of a compound of formula (I), or a pharmaceutically acceptable salt thereof, b) one or more, e.g. 1, 2 or 3, surfactants with lubricant properties; c) one or more, e.g. 1, 2 or 3, dry binders with disintegrant properties; d) one or more, e.g. 1, 2 or 3, fillers, and e) one or more, e.g. 1, 2 or 3, disintegrants.
    Type: Application
    Filed: July 22, 2015
    Publication date: November 12, 2015
    Applicant: NOVARTIS AG
    Inventors: Hong Wen, Natrajan Kumaraperumal, Richard Nause
  • PHARMACEUTICAL COMPOSITIONS CONTAINING A DGAT1 INHIBITOR
    Publication number: 20130190354
    Abstract: The present invention relates to a pharmaceutical composition comprising a therapeutically effective amount of a compound of formula (I), or a pharmaceutically acceptable salt thereof, one or more surfactants with lubricant properties, one or more dry binders with disintegrant properties, one or more fillers and one or more disintegrants.
    Type: Application
    Filed: October 14, 2011
    Publication date: July 25, 2013
    Applicant: NOVARTIS AG
    Inventors: Hong Wen, Natrajan Kumaraperumal, Richard Nause